EAU 2013 - Programme Book - YouMed

Monday, 18 March - EAU Programme
Abstract Session
14.00 - 15.30 Nephrectomy for RCC: Minimally invasive techniques, renal function,
lymph node dissection and prognostic factors
Silver Hall - Level N2
Poster Session 78
Chairs: J. Ramon, Tel Aviv (IL)
R.E. Zigeuner, Graz (AT)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
* 948 Hybrid transvaginal natural orifice transluminal endoscopic surgery (NOTES) nephrectomy: Our experience
X. Zou, G. Zhang, Y. Xue, R. Xiao, Y. Yuan, G. Wu, X. Wang, D. Long, Y. Wu, F. Liu, Y. Liao (Ganzhou, China)
949 Laparoendoscopic single-site and conventional laparoscopic radical nephrectomy result in an equivalent
surgical trauma: Preliminary results of a single-centre retrospective controlled study
F. Greco, C. Springer, P. Fornara (Halle Saale, Germany)
950 Novel three-dimensional head-mounted display system (RoboSurgeon System) - application to the initial
60 cases of gasless single-port access urologic surgeries
K. Kihara, H. Takeshita, H. Masuda, F. Koga, K. Saito, Y. Matsuoka, N. Numao, Y. Fujii (Tokyo, Japan)
951 Renal functional deterioration caused by radical nephrectomy affect comprehensive prognosis in patients
with T1 renal cell carcinoma
T. Sejima, H. Iwamoto, T. Masago, S. Morizane, A. Yao, T. Isoyama, A. Takenaka (Yonago, Japan)
952 Lymphadenopathy with renal carcinoma: Pathologic or reactive?
A. Raja, H. Stunell, T.F. Aho, S.S. Connolly (Cambridge, United Kingdom)
953 When to perform lymph node dissection in renal cell carcinoma patients: A novel approach to
preoperatively assess the risk of lymph node invasion at surgery and nodal progression during follow up
U. Capitanio, F. Abdollah, R. Matloob, A. Gallina, F. Pellucchi, A. Russo, P. Capogrosso, M. Moschini, E. Di
Trapani, C. Carenzi, M. Roscigno, P. Rigatti, R. Bertini (Milan, Bergamo, Italy)
954 The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (mRCC) who are the
candidates for targeted therapy
A.V. Klimov, V. Matveev, M. Volkova, V.I. Shirokorad, M. Peters (Moscow, Russia)
955 Preoperative R.E.N.A.L. nephrometry score as a predictor of pathologic stage in renal cell carcinoma
J.Y. Chae, J.W. Kim, J.W. Kim, M.M. Oh, D.G. Moon, C.Y. Yoon (Seoul, South Korea)
956 Benefit in regionalization of care for patients treated with nephrectomy: A nationwide inpatient sample
A. Abdo, N. Hanna, P.I. Karakiewicz, A. Becker, F. Roghmann, M. Meskawi, Q-D. Trinh (Montreal, Canada;
Hamburg, Herne, Germany)
957 The impact of non-clear cell histology on outcome for patients with renal cell carcinoma and venous tumor
thrombus
S. Boorjian, D. Kaushik, R.H. Thompson, M.S. Eisenberg, C.M. Lohse, J. Cheville, B.C. Leibovich (Rochester,
United States of America)
958 Prognostic factors and risk groups in primary extensive renal cell carcinoma
A.V. Poluyanchik, L.V. Mirylenka, O.G. Sukonko, A.I. Rolevich, A. Minich (Minsk, Belarus)
EAU Milan 2013
289
Monday